Zobrazeno 1 - 10
of 203
pro vyhledávání: '"Mauro Moroni"'
Autor:
Mauro Moroni, Marco Pirovano, Silvia Brugnatelli, Martina Zucca, Marco Morreale, Vittoria Rizzo, Alessandra Ferrari, Carmine Tinelli, Annalisa De Silvestri, Maurizio Meregalli, Monica Giordano, Salvatore Artale, Massimiliano Cergnul, Roberto Bollina, Mimma Rizzo, Paolo Pedrazzoli
Publikováno v:
Journal of Functional Foods, Vol 83, Iss , Pp 104533- (2021)
Epidermal Growth Factor Receptor (EGFR) inhibition leads to the production of reactive oxygen metabolites causing skin inflammatory reactions. Anti-EGFR therapies are frequently associated with skin toxicities which often cause treatment delay and im
Externí odkaz:
https://doaj.org/article/1ebb82f2c6d34a42be59ce78c7d7fbc5
Autor:
Salvatore Artale, Nunziata Grillo, Stefano Lepori, Chiara Butti, Antonella Bovio, Sabrina Barzaghi, Andrea Colombo, Elena Castiglioni, Lucia Barbarini, Laura Zanlorenzi, Paola Antonelli, Riccardo Caccialanza, Paolo Pedrazzoli, Mauro Moroni, Sabrina Basciani, Rebecca Azzarello, Francesco Serra, Alessandra Trojani
Publikováno v:
Nutrients, Vol 14, Iss 9, p 1801 (2022)
This study aimed to determine if dietary modifications using a nutritional regimen could prevent or reduce the incidence of cancer therapy-induced diarrhea in patients with metastatic colorectal cancer and to evaluate the relationship of Vitamin D bl
Externí odkaz:
https://doaj.org/article/fea3cd14a6b94f038cc672ebde69ece0
Autor:
Sandro Barni, Gerardo Rosati, Sara Lonardi, Nicoletta Pella, Maria Banzi, Maria G. Zampino, Katia F. Dotti, Lorenza Rimassa, Paolo Marchetti, Evaristo Maiello, Fabrizio Artioli, Daris Ferrari, Roberto Labianca, Paolo Bidoli, Alberto Zaniboni, Alberto Sobrero, Vincenzo Iaffaioli, Sabino De Placido, Gian Luca Frassineti, Andrea Ciarlo, Angela Buonadonna, Nicola Silvestris, Elena Piazza, Lorenzo Pavesi, Mauro Moroni, Mario Clerico, Massimo Aglietta, Paolo Giordani, Francesca Galli, Fabio Galli, Fausto Petrelli
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: The risk of venous thromboembolic events (VTE) during adjuvant chemotherapy for colorectal cancer (CRC) is unknown. We aim to evaluate if the Khorana score (KS) can predict this risk, and if it represents a prognostic factor for overall s
Externí odkaz:
https://doaj.org/article/74e23a79e30941658f91df4b811b4429
Autor:
Andrea Gori, Alessandra Bandera, Giulia Marchetti, Anna Degli Esposti, Lidia Catozzi, Gian Piero Nardi, Lidia Gazzola, Giulio Ferrario, Jan D.A. van Embden, Dick van Soolingen, Mauro Moroni, Fabio Franzetti
Publikováno v:
Emerging Infectious Diseases, Vol 11, Iss 8, Pp 1242-1248 (2005)
We evaluated the clinical usefulness of spoligotyping, a polymerase chain reaction–based method for simultaneous detection and typing of Mycobacterium tuberculosis strains, with acid-fast bacilli–positive slides from clinical specimens or mycobac
Externí odkaz:
https://doaj.org/article/e285007b2ad545c0b2575a7c700d388a
Publikováno v:
Oncology Reviews, Vol 3, Iss 3 (2011)
The recent introduction of targeted therapies in the treatment of patients with metastatic colorectal cancer (mCRC) not only improved efficacy but also toxicity and costs of the therapy, therefore requiring the identification of decision-making tools
Externí odkaz:
https://doaj.org/article/a23e48ef7fb94b1a8cc2565a74728aa3
Autor:
Andrea Zuccarini, Daniela Cicognini, Richard Tancredi, Alessandra Ferrari, Gianpiero Rizzo, Angioletta Lasagna, Riccardo Caccialanza, Luigi Cavanna, Elena Orlandi, Claudia Biasini, Peppina Molinaro, Danula Garigliano, Angela Costantino, Mauro Moroni, Lorenzo Perrone, Niccolò Leandro Alessio, Bianca Rovati, Virginia Valeria Ferretti, Catherine Klersy, Paolo Pedrazzoli
Publikováno v:
Supportive Care in Cancer. 30:7645-7653
Iron supplementation improves the erythropoiesis-stimulating agents' (ESAs) response in chemotherapy-related anemia. The primary aim of our study is to assess the efficacy of sucrosomial iron, a new oral iron formulation, in cancer patients with chem
Autor:
Massimiliano Cergnul, Monica Giordano, Marco Morreale, Mauro Moroni, Marco Pirovano, Paolo Pedrazzoli, Silvia Brugnatelli, Mimma Rizzo, Carmine Tinelli, Maurizio Meregalli, Roberto Bollina, Martina Zucca, Alessandra Ferrari, Salvatore Artale, Annalisa De Silvestri, Vittoria Rizzo
Publikováno v:
SSRN Electronic Journal.
Background: EGFR inhibition leads to the production of reactive oxygen metabolites, causing skin inflammatory reactions. Lycopene has an extreme antioxidant activity and, due to its hydrophobic structure, accumulates specifically in the skin. Methods
Autor:
Massimiliano Cergnul, Monica Giordano, Maurizio Meregalli, Mauro Moroni, Mimma Rizzo, Marco Morreale, Paolo Pedrazzoli, Marco Pirovano, Annalisa De Silvestri, Roberto Bollina, Martina Zucca, Carmine Tinelli, Vittoria Rizzo, Alessandra Ferrari, Silvia Brugnatelli, Salvatore Artale
Publikováno v:
Journal of Functional Foods, Vol 83, Iss, Pp 104533-(2021)
Epidermal Growth Factor Receptor (EGFR) inhibition leads to the production of reactive oxygen metabolites causing skin inflammatory reactions. Anti-EGFR therapies are frequently associated with skin toxicities which often cause treatment delay and im
Autor:
Francesca Galli, Nicola Silvestris, A. Ciarlo, Daris Ferrari, Mauro Moroni, E. Piazza, Fabrizio Artioli, Sabino De Placido, Lorenzo Pavesi, Paolo Bidoli, F. Galli, Alberto Sobrero, Roberto Labianca, Gerardo Rosati, Fausto Petrelli, Angela Buonadonna, Gian Luca Frassineti, Sara Lonardi, Lorenza Rimassa, Sandro Barni, Katia Fiorella Dotti, Mario Clerico, Nicoletta Pella, Maria Banzi, Massimo Aglietta, Maria Giulia Zampino, Vincenzo Rosario Iaffaioli, Evaristo Maiello, Paolo Marchetti, Paolo Giordani, Alberto Zaniboni
Publikováno v:
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: The risk of venous thromboembolic events (VTE) during adjuvant chemotherapy for colorectal cancer (CRC) is unknown. We aim to evaluate if the Khorana score (KS) can predict this risk, and if it represents a prognostic factor for overall s
Autor:
Pier Adelchi Ruffini, Juping Yuan, Mauro Moroni, Massimo Broggini, Giovanni Rosti, Klaus Strebhardt, Silvio Veronese, Andrea Sartore-Bianchi, Ugo De Giorgi
Publikováno v:
The International Journal of Biological Markers. 30:275-281
Germ cell tumors (GCTs) generally express wild-type p53 protein. Rare p53 mutations may be associated with cisplatin resistance. There is growing interest in the role of cyclins as targets for GCTs. Cyclin B1 is involved in G2/M transition and its ov